The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 301–400 of 1,010
Redox regulation of tumor suppressor PTEN in cell signaling
Zhang, Y., Park, J., Han, S.-J., Yang, S. Y., Yoon, H. J., Park, I., Woo, H. A., & Lee, S.-R. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101553 · Cited by 92
Antagonism between FOXO and MYC Regulates Cellular Powerhouse
Peck, B., Ferber, E. C., & Schulze, A. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00096 · Cited by 88
Activated lymphocytes as a metabolic model for carcinogenesis
Macintyre, A. N., & Rathmell, J. C. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-5 · Cited by 88
PTEN proteoforms in biology and disease
Malaney, P., Uversky, V. N., & Davé, V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2500-6 · Cited by 85
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
Cretella, D., Digiacomo, G., Giovannetti, E., & Cavazzoni, A. (2019) · Cancers · doi:10.3390/cancers11091318 · Cited by 92
Kang, J., Li, Z., Zhi, Z., Wang, S., & Xu, G. (2019) · Gene Therapy · doi:10.1038/s41434-019-0101-8 · Cited by 93
Dormant Intestinal Stem Cells Are Regulated by PTEN and Nutritional Status
Richmond, C. A., Shah, M. S., Deary, L. T., Trotier, D., Thomas, H. R., Ambruzs, D. M., Jiang, L., Whiles, B. B., Rickner, H., Montgomery, R. K., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.035 · Cited by 99
Lin, F., de Gooijer, M. C., Hanekamp, D., Chandrasekaran, G., Buil, L. C. M., Thota, N., Sparidans, R. W., Beijnen, J. H., Würdinger, T., & van Tellingen, O. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1276 · Cited by 90
The genetics of melanoma: recent advances
Hill, V. K., Gartner, J. J., Samuels, Y., & Goldstein, A. M. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153429 · Cited by 86
The microRNA signatures: aberrantly expressed miRNAs in prostate cancer
Sharma, N., & Baruah, M. M. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1910-8 · Cited by 91
PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage
Zhang, J., Lee, Y.-R., Dang, F., Gan, W., Menon, A. V., Katon, J. M., Hsu, C.-H., Asara, J. M., Tibarewal, P., Leslie, N. R., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0083 · Cited by 87
Self-citationPTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target
Salvatore, L., Calegari, M. A., Loupakis, F., Fassan, M., Stefano, B. D., Bensi, M., Bria, E., & Tortora, G. (2019) · Cancers · doi:10.3390/cancers11111765 · Cited by 97
Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Yang, B., Lin, Y., Huang, Y., Shen, Y.-Q., & Chen, Q. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103032 · Cited by 99
“Conversely, Ras can phosphorylate PTEN leading to impairment of its phosphatase activity, resulting in the activation of the PI3K/Akt pathway [133,134].”
BackgroundKreis, P., Leondaritis, G., Lieberam, I., & Eickholt, B. J. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00023 · Cited by 86
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops
Eibl, G., & Rozengurt, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 85
PTEN regulates DNA replication progression and stalled fork recovery
He, J., Kang, X., Yin, Y., Chao, K. S. C., & Shen, W. H. (2015) · Nature Communications · doi:10.1038/ncomms8620 · Cited by 85
Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease
Kerr, K. M., Qualmann, K. J., Esquenazi, Y., Hagan, J. P., & Kim, D. (2018) · Neurosurgery · doi:10.1093/neuros/nyy121 · Cited by 90
Zhang, L.-L., Mu, G., Ding, Q., Li, Y., Shi, Y., Dai, J., & Yu, H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641407 · Cited by 88
Mok, K., Mruk, D. D., & Cheng, C. Y. (2013) · International review of cytology · doi:10.1016/b978-0-12-407704-1.00006-3 · Cited by 90
Potočnjak, I., & Domitrović, R. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.11.004 · Cited by 87
mTORC1 senses stresses: Coupling stress to proteostasis
Su, K., & Dai, C. (2017) · BioEssays · doi:10.1002/bies.201600268 · Cited by 85
A neuroprotective phase precedes striatal degeneration upon nucleolar stress
Kreiner, G., Bierhoff, H., Armentano, M., Parkitna, J. M. R., Sowodniok, K., Naranjo, J. R., Bonfanti, L., Liss, B., Schütz, G., Grummt, I., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.66 · Cited by 88
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 88
Tang, S., Tan, G., Jiang, X. L., Han, P., Zhai, B., Dong, X., Qiao, H., Jiang, H., & Sun, X. (2016) · Oncotarget · doi:10.18632/oncotarget.12304 · Cited by 85
Eide, P. W., Cekaite, L., Danielsen, S. A., Eilertsen, I. A., Kjenseth, A., Fykerud, T. A., Ågesen, T. H., Bruun, J., Rivedal, E., Lothe, R. A., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.08.012 · Cited by 83
USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma
Lu, C., Ning, Z., Wang, A., Chen, D., Liu, X., Xia, T., Tekcham, D. S., Wang, W., Li, T., Liu, X., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.032 · Cited by 87
Nilendu, P., Sarode, S. C., Jahagirdar, D., Tandon, I., Patil, S. V., Sarode, G. S., Pal, J. K., & Sharma, N. K. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0388-2 · Cited by 85
Hall, C. P., Reynolds, C. P., & Kang, M. H. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0114 · Cited by 86
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · PubMed · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 79
PI(3,4)P2 Signaling in Cancer and Metabolism
Gozzelino, L., De Santis, M. C., Gulluni, F., Hirsch, E., & Martini, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00360 · Cited by 79
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells
Sacco, J. J., Yau, T. Y., Darling, S., Patel, V, Liu, H., Urbé, S., Clague, M. J., & Coulson, J. M. (2014) · Oncogene · doi:10.1038/onc.2013.512 · Cited by 80
Malaney, P., Pathak, R. R., Xue, B., Uversky, V. N., & Davé, V. (2013) · Scientific Reports · doi:10.1038/srep02035 · Cited by 79
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons, L., & Kelly, G. L. (2017) · Viruses · doi:10.3390/v9110339 · Cited by 86
Wang, Y., Lin, J., Tian, J., Si, X., Jiao, X., Zhang, W., Gong, E. S., & Li, B. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06209 · Cited by 79
PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression
Zhang, L.-L., Liu, J., Shen, L., Zhang, J., Zhou, W., & Yu, H. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.025 · Cited by 85
Carrà, G., Panuzzo, C., Torti, D., Parvis, G., Crivellaro, S., Familiari, U., Volante, M., Morena, D., Lingua, M. F., Brancaccio, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16348 · Cited by 77
Self-citationMolecular Oncology of Breast Cancer
Joshi, H. N., & Press, M. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35955-9.00022-2 · Cited by 97
Systemic Inhibition of CREB is Well-tolerated in vivo
Li, B. X., Gardner, R. T., Xue, C., Qian, D. Z., Xie, F., THOMAS, G. V., Kazmierczak, S. C., Habecker, B. A., & Xiao, X. (2016) · Scientific Reports · doi:10.1038/srep34513 · Cited by 90
Liu, G., Liu, S., Xing, G., & Wang, F. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.02.007 · Cited by 84
RetractedZhou, B., Gao, Y., Zhang, P., & Chu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693609 · Cited by 90
Ge, X. Q., Li, M., Yin, J., Shi, Z., Fu, Y. S., Zhao, N., Chen, H., Meng, L., Li, X., Hu, Z., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.029 · Cited by 88
Kinases, tails and more: Regulation of PTEN function by phosphorylation
Fragoso, R., & Barata, J. T. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.015 · Cited by 82
Masson, G. R., Perišić, O., Burke, J. E., & Williams, R. L. (2015) · Biochemical Journal · doi:10.1042/bj20150931 · Cited by 80
Li, R., Gao, J., Guo, L.-H., Huang, G.-Q., & Luo, W.-H. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.29 · Cited by 78
Deregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression
Tang, J., Gifford, C., Samarakoon, R., & Higgins, P. (2018) · Cancers · doi:10.3390/cancers10060159 · Cited by 77
Jung, K., Kim, M., So, J., Lee, S., Ko, S., & Shin, D. (2021) · Hepatology · doi:10.1002/hep.31679 · Cited by 77
Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability
Cui, Y., Wang, Y., Song, X., Ning, H., Zhang, Y., Teng, Y., Wang, J., & Yang, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109327 · Cited by 86
βIII-Tubulin Gene Regulation in Health and Disease
Duly, A. M. P., Kao, F. C. L., Teo, W. S., & Kavallaris, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.851542 · Cited by 90
Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair
Liu, P., Gan, W., Guo, C., Xie, A., Gao, D., Guo, J., Zhang, J., Willis, N. A., Su, A., Asara, J. M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.005 · Cited by 90
Li, J., Hu, K., Gong, G., Zhu, D. L., Wang, Y., Liu, H., & Wu, X. (2017) · Scientific Reports · doi:10.1038/srep41330 · Cited by 79
Mao, X., Chen, M., Wang, Y., Cui, P., Liu, S., & Xu, Z. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22542 · Cited by 76
Xu, W., Yang, Z., Xie, C., Zhu, Y., Shu, X., Zhang, Z., Li, N., Chai, N., Zhang, S., Wu, K., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0795-2 · Cited by 80
Epigenetic regulation in lung cancer
Ramazi, S., Dadzadi, M., Sahafnejad, Z., & Allahverdi, A. (2023) · MedComm · doi:10.1002/mco2.401 · Cited by 97
The multiple layers of non-genetic regulation of PTEN tumour suppressor activity
Correia, N., Gírio, A., Antunes, I., Martins, L. R., & Barata, J. T. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.017 · Cited by 83
PIP kinases define PI4,5P2 signaling specificity by association with effectors
Choi, S., Thapa, N., Tan, X., Hedman, A. C., & Anderson, R. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.01.009 · Cited by 75
Wang, H., Guan, X., Tu, Y.-S., Zheng, S., Long, J., Li, S., Qi, C., Xie, X., Zhang, H., & Zhang, Y. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0169-y · Cited by 76
Regev, K., Healy, B. C., Khalid, F., Paul, A., Chu, R., Tauhid, S., Tummala, S., Diaz-Cruz, C., Raheja, R., Mazzola, M. A., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5197 · Cited by 68
Wozniak, D. J., Kajdacsy‐Balla, A., Macias, V., Ball-Kell, S. M., Zenner, M. L., Bie, W., & Tyner, A. L. (2017) · Nature Communications · doi:10.1038/s41467-017-01574-5 · Cited by 86
PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression
Park, M. K., Yao, Y., Xia, W., Setijono, S. R., Kim, J. H., Vila, I. K., Chiu, H.-H., Wu, Y., González‐Billalabeitia, E., Lee, M. G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08481-x · Cited by 82
Self-citationInositol lipid phosphatases in membrane trafficking and human disease
Billcliff, P. G., & Lowe, M. (2014) · Biochemical Journal · doi:10.1042/bj20140361 · Cited by 82
Perumal, E., Youn, K. S., Shin, S. Y., Seung-Hyun, J., Suji, M., Jieying, L., & Chung, Y. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.01.013 · Cited by 84
Ashrafizadeh, M., Najafi, M., Ang, H. L., Moghadam, E. R., Mahabady, M. K., Zabolian, A., Jafaripour, L., Bejandi, A. K., Hushmandi, K., Saleki, H., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8080264 · Cited by 78
Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review)
Meng, D., He, W. A., Zhang, Y., Liang, Z., Zheng, J., Zhang, X., Zheng, X., Zhan, P., Chen, H., Li, W.-J., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105900 · Cited by 79
A DNA Methylation Prognostic Signature of Glioblastoma: Identification of NPTX2-PTEN-NF-κB Nexus
Shukla, S. K., Patric, I. R. P., Thinagararjan, S., Srinivasan, S., Mondal, B., Hegde, A. S., Chandramouli, B. A., Santosh, V., Arivazhagan, A., & Somasundaram, K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0298 · Cited by 83
MAF1 suppresses AKT‐mTOR signaling and liver cancer through activation of PTEN transcription
Li, Y., Tsang, C. K., Wang, S., Li, X., Yang, Y., Fu, L., Huang, W., Li, M., Wang, H., & Zheng, X. F. S. (2016) · Hepatology · doi:10.1002/hep.28507 · Cited by 78
PTEN inhibitors: An evaluation of current compounds
Spinelli, L., Lindsay, Y. E., & Leslie, N. R. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.012 · Cited by 83
SUN, H.-B., Chen, X., Ji, H. L., Wu, T., Lü, H., Zhang, Y., Li, H., & Li, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2665 · Cited by 82
Chan, X. Y., Black, R., Dickerman, K., Federico, J., Lévesque, M., Mumm, J., & Gerecht, S. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306362 · Cited by 74
Angiocrine polyamine production regulates adiposity
Monelli, E., Villacampa, P., Zabala‐Letona, A., Martínez-Romero, A., Llena, J., Beiroa, D., Gouveia, L., Chivite, Í., Zagmutt, S., Gama-Pérez, P., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00544-6 · Cited by 77
Mesenchymal Stem Cell-Derived Extracellular Vesicles for Bone Defect Repair
Wang, D., Cao, H., Hua, W., Gao, L., Yuan, Y. J., Zhou, X., & Zeng, Z. (2022) · Membranes · doi:10.3390/membranes12070716 · Cited by 77
Lou, S.-C., Gong, D., Yang, M., Qiu, Q., Luo, J., & Chen, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105123 · Cited by 83
“Phosphatase and tensin homolog deleted on chromosome ten (PTEN) is a tumor suppressor gene and an inhibitor of PI3K/Akt which has been reported to modulate oncogenesis in the study of cancers [49].”
BackgroundGangula, N. R., & Maddika, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503383 · Cited by 75
Horita, H. N., Wysoczynski, C. L., Walker, L. A., Moulton, K. S., Li, M., Ostriker, A. C., Tucker, R. M., McKinsey, T. A., Churchill, M. E. A., Nemenoff, R. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms10830 · Cited by 76
Eder, T., Weber, A., Neuwirt, H., Grünbacher, G., Ploner, C., Klocker, H., Sampson, N., & Eder, I. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091458 · Cited by 74
Han, C. Y., Koo, J. H., Kim, S. H., Gardenghi, S., Rivella, S., Strnad, P., Hwang, S. J., & Kim, S. G. (2016) · Nature Communications · doi:10.1038/ncomms13817 · Cited by 74
Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis
Liu, Y., Lu, X., Huang, L., Wang, W., Jiang, G., Dean, K. C., Clem, B. F., Telang, S., Jenson, A. B., Cuatrecasas, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6660 · Cited by 80
Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
Balandeh, E., Mohammadshafie, K., Mahmoudi, Y., Pourhanifeh, M. H., Rajabi, A., Bahabadi, Z. R., Mohammadi, A. H., Rahimian, N., Hamblin, M. R., & Mirzaei, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716462 · Cited by 76
He, Y., Yue, H., Cheng, Y., Ding, Z., Xu, Z. D., Lv, C., Wang, Z., Wang, J., Yin, C., Hao, H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04401-4 · Cited by 77
Genetic Deletion of Cadm4 Results in Myelin Abnormalities Resembling Charcot-Marie-Tooth Neuropathy
Golan, N., Kartvelishvily, E., Spiegel, I., Salomon, D., Sabanay, H., Rechav, K., Vainshtein, A., Frechter, S., Maik-Rachline, G., Eshed-Eisenbach, Y., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0571-13.2013 · Cited by 73
Genetic deregulation of the PIK3CA oncogene in oral cancer
Murugan, A. K., Munirajan, A. K., & Tsuchida, N. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.04.005 · Cited by 75
Study of PTEN subcellular localization
Bononi, A., & Pinton, P. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.002 · Cited by 81
Hale, A. J., ter Steege, E. J., & den Hertog, J. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.03.023 · Cited by 74
The Therapeutic Potential of PTEN Modulation: Targeting Strategies from Gene to Protein
McLoughlin, N. M., Mueller, C., & Grossmann, T. N. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.009 · Cited by 81
Qiao, Q., & Li, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.160 · Cited by 72
PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context
Schmit, F., Utermark, T., Zhang, S., Wang, Q., Von, T., Roberts, T. M., & Zhao, J. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323004111 · Cited by 72
The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis
Hsu, F., & Mao, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.015 · Cited by 71
Errafiy, R., Aguado, C., Ghislat, G., Esteve, J. M., Gil, A., Loutfi, M., & Knecht, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083318 · Cited by 72
Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas
Ebbesen, S. H., Scaltriti, M., Bialucha, C. U., Morse, N., Kastenhuber, E. R., Wen, H. Y., Dow, L. E., Baselga, J. M., & Lowe, S. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523693113 · Cited by 80
MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation
Radhakrishnan, H., Walther, W., Zincke, F., Kobelt, D., Imbastari, F., Erdem, M., Kortüm, B., Dahlmann, M., & Stein, U. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9771-8 · Cited by 83
Ubiquitin-binding site 2 of ataxin-3 prevents its proteasomal degradation by interacting with Rad23
Blount, J. R., Tsou, W., Ristic, G., Burr, A. A., Ouyang, M., Galante, H., Scaglione, K. M., & Todi, S. V. (2014) · Nature Communications · doi:10.1038/ncomms5638 · Cited by 76
Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
Chen, J., Zhao, K., Li, R., Shao, R., & Chen, C. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140414095605 · Cited by 77
G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling
Riaz, A., Huang, Y., & Johansson, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020215 · Cited by 66
Exosomes derived from M2 macrophages induce angiogenesis to promote wound healing
Lyu, L., Cai, Y., Zhang, G., Jing, Z., Liang, J., Zhang, R., Dang, X., & Zhang, C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1008802 · Cited by 77
Guéguinou, M., Gambade, A., Félix, R., Chantôme, A., Fourbon, Y., Bougnoux, P., Weber, G., Potier‐Cartereau, M., & Vandier, C. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.036 · Cited by 78
Floris, G., Woźniak, A., Sciot, R., Li, H., Friedman, L. S., Looy, T. V., Wellens, J., Vermaelen, P., Deroose, C. M., Fletcher, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2853 · Cited by 74
“GIST882Ly ↑ 680 [137-1223] ↑ 145 [75-216]** ↑ 224 [120-328] ↓ 22 [19-25]** = 95 [-97-287] ↓ 25 [3-48]”
InfluentialAttacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 69
Wang, J., Zhu, H. H., Chu, M., Liu, Y., Zhang, C., Liu, G., Yang, X., Yang, R., & Gao, W. (2014) · Nature Communications · doi:10.1038/ncomms5758 · Cited by 69
Hensel, N., Rademacher, S., & Claus, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00198 · Cited by 69
Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model
Wang, Z., Xu, D., Ding, H.-F., Kim, J., Zhang, J., Hai, T., & Yan, C. (2014) · Oncogene · doi:10.1038/onc.2014.426 · Cited by 71
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.